Well, yeah - looks like the same guy to me. I'm afraid I fail to see your point here, dear kickstones (whereas your point about Chiara Bonini and her oddly inconsistent looks - and apparent age - had some merit...)
Dear Simon, if I remember rightly, you once questioned, along the lines, if US soldiers really existed to the numbers they are made out be oversees.
I'm just questioning the existence of the members of the team at the Hematology Unit, San Raffaele Scientific Institute.
Chiara Bonini looks, to my eyes, are clearly different.
I agree, Dr. Fabio Ciceri's latter profiles are similar, however, the initial two i'm not so sure about. And the second one, according to fotoforensics data,
had a Modify Date in 2013.
Obviously they got to have someone appear on PharmaStar TV you tube programmes etc..its not beyond the realms of the imagination that these could be hired help playing to a script. This could be there 'Paris' moment.
Only this a different agenda, continued and justified funding on the basis they put out news annoucement of 'new ground breaking cure / therapy', how often we heard that statement. However, it's not certain it works so they got to keep on researching for a few more heavily funded years.
This is what now appears, only came across it today on, Chiara Bonini Curriculum Vitae.....
• 1994: MD, Università degli Studi di Milano, Italy, Summa cum laude.
• 1998: National Board in Hematology, University of Pavia, Summa cum laude.
• 2008 – present: Head of the Experimental Hematology Unit, San Raffaele Scientific Institute, MI
• 2004- present: Assistant Professor in the “Speciality School of Hematology” and in the “School of Biotechnology “Università Vita-Salute San Raffaele”, Milano
• 2000-present: Assistant Professor in Hematology in the School of Medicine,“ Università Vita-Salute San Raffaele”, Milano. Assistant, Supervisor and examiner of PhD students enrolled in the Open University Program, Program in Molecular Medicine, HSR, PhD Open University Program, Hammersmith Hospital, London, UK.
• 1998-present: Attending Physician, Bone Marrow Transplant Unit, H.S. Raffaele, Milano, Italy (in leave of absence 1998-2000).
• 2000-2008: Group Leader, of the Experimental Hematology Unit, Cancer Immunotherapy and Gene Therapy Program, San Raffaele Scientific Institute, Milano, Italy
• 2001-2007: Principal Investigator of the multicentric clinical trial TK007" A phase I-II study: Infusion of donor lymphocytes that have been engineered with the suicide gene HSV-tk after transplantation of allogeneic T-depleted stem cells from a haploidentical donor in patients with hematological malignancies” sponsored by Molmed s.p.a. Centers involved: H.S.Raffaele, Milan; Hadassah University Hospital, Jerusalem; Hammersmith Hospital, London, Humanitas, Milano.
• 1998-2000: Post-doctoral fellow, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle. Cancer Research Institute Fellowship
• 1996-1998: Post-doctoral fellow, TIGET (Telethon Istitute for Gene Therapy), DIBIT, H.S. Raffaele, Milano, Italy
• 1995-1997: Medical fellow, Bone Marrow Transplant Unit, H.S. Raffaele, Milano, Italy.
• 1994-1998: Principal Investigator of the clinical trial " Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.” San Raffaele Scientific Institute, Milano,
• 1993: Undergraduate summer student, Bone Marrow Transplantation Unit, Memorial Sloan Kettering Cancer Center, New York, USA.
• 1991-1994: Undergraduate student, Laboratory of Experimental Hematology, H San Raffaele, Milano, Italy.
Activity as national or international expert/reviewer
• 2009-present: Associate Editor Journal of Gene Medicine.
• 2009-Present: Member of the Cancer Gene Therapy Committee, American Society of Gene Therapy
• 2005-present: Member of the Board of the European Society of Gene Therapy
• 2005-present:Grant reviewer for INSERM, The Netherland organization for Health Research and Development (ZonMw), Cancer Research UK, Leukemia Research
• 2000-present: Member of the American Society of Cell and Gene Therapy, European Society of Gene Therapy, American Society of Hematology, Immunobiology WP of the European Society of BMT.
• 1995-Present: Reviewer for Blood, Human Gene Therapy, The Journal of Gene Medicine, Bone Marrow Transplantation, Human Immunology, Mol Ther, Cytotherapy, Exp Hematol, Mol Ther., Hematologica.,
• 2006: Young Investigator Award. Fondazione Berlucchi
• 2005: Young Investigator Award. American Society of Gene Therapy
• 2009-2013-MIUR-FIRB Ideas (ERC-starting grant) (PI: Chiara Bonini): T cell receptor gene editing by designed zinc finger nucleases and lentiviral vectors for adoptive immune therapy of leukemia. Funding available: 1.230.120,00. Euro
• 2008-2010 Progetto Strategico Oncologia (PI: C. Bordignon): Adoptive immune-gene therapy for tumors. Funding available: 230.000 Euro.
• 2009-2011 Giovani Ricercatori Ministero Salute (PI: Chiara Bonini): T lymphocyte gene editing to cure leukemias Funding available: 600,00. Euro
• 2009-2010 Fondazione Telethon (PI Giulio Cossu): Cell therapy of Duchenne Muscular Dystrophy by intra-arterial delivery of donor, HLA-matched mesoangioblasts. Funding available: 135.000.
• 2009-2012 EU (PI Luigi Naldini): PERSIST Funding available: 200.000.
Is this the joke?
http://www.hsr.it/research/organization ... -bonini/3/
I don't know Simon, maybe everything is above board, I'm just not excepting everything at face value, just putting this out there so folk can verify the situation. Because for me the below picture doesn't sit right, especially when magnified. ( I'd put a few example on the post, but I'm not that skilled)
I suppose, at the end of the day all someone has to do is wait outside San Raffaele Scientific Institute and photograph these people.